Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a suspicious mass near the ovaries or fallopian tubes that will be examined by biopsy during surgery, or people who have already been diagnosed with early-stage ovarian cancer confirmed by a pathology report, with full surgical staging planned.
- People whose scans before surgery show no sign that cancer has spread to lymph nodes behind the abdomen or to other parts of the body.
- People who have signed a consent form agreeing to take part in the study (or whose authorised relative has signed on their behalf).
- Women who could become pregnant must agree to use a highly effective method of contraception (such as a partner who has had a vasectomy, or complete abstinence from sex) until the end of the study.
Who may not be able to join:
- People under 18 years of age.
- People who are pregnant or currently breastfeeding.
- People whose ovarian cancer has been classified as stage III or stage IV (meaning it has spread significantly beyond the ovary).
- People where it is not possible to take a biopsy sample from the tumour during surgery.
- People who have previously had surgery on major blood vessels in the abdomen (such as the large vein or main artery) or who have had radiotherapy to the pelvic or upper abdominal area.
- People whose tumour, when examined during surgery, turns out to be non-cancerous, low-risk (borderline), or a specific type called expansive mucinous — in these cases, a particular part of the trial procedure will not be carried out.
- People who are not well enough to undergo surgery.
- People who have a known allergy or sensitivity to the study substance, to sodium iodide, or to iodine.
- People who have an overactive thyroid gland or certain thyroid conditions involving abnormal activity in part or all of the thyroid (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Berta Diaz-Feijoo, Physician, Hospital Clinic of Barcelona
Phone: 0034 932275400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the diagnostic efficiency of both tracers in sentinel lymph node detection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.